Japan pain management drugs market is anticipated to grow at a CAGR of 2.98% from 2025 to 2030.
Highlights:
- 1Aging population growing rapidlySeniors are experiencing more age-related chronic pain conditions daily.
- 2Chronic pain cases rising steadilyMillions of residents are seeking effective relief for persistent discomfort.
- 3Cancer patients requiring better controlIndividuals are managing treatment-related pain with advanced pharmacological options.
- 4Healthcare access expanding nationwideGovernment initiatives are improving the availability of pain relief drugs in rural areas.
- 5OTC sales progressing quicklyConsumers are increasingly purchasing over-the-counter analgesics for everyday pain management.
Japan Pain Management Drugs Market Trends:
The market growth is majorly attributed to the rising geriatric population in Japan, and low fertility rates, coupled with improving life expectancy on account of improving nutrition, low prevalence of diseases, and availability of state-of-the-art medical and pharmacological technologies in the country, which is increasing the number of older people.
According to the “Statistical Handbook of Japan 2024”, issued by the Ministry of Internal Affairs and Communication, by 2050, the population aged 65 years and above will account for 38.7% of the total population. Likewise, as per the “Annual Report on Annual Society FY2024”, as of October 2023, the population aged 74 years and above was 20.08 million and accounted for 16.1% of the total population.
Besides the growing old-age population, the chronic disease prevalence in Japan has also shown constant growth over the years, which is also anticipated to drive the demand for pain management drugs as they assist in refracting pain. According to the Global Cancer Observatory, in 2022, nearly 1,005,157 new cancer cases were reported in Japan, and the number of deaths reached 426,278. Hence, the same source also stated that prostate, lung, and stomach-related cancer cases were most commonly reported.
Moreover, the favorable policies and schemes by the Japanese government to increase healthcare access to rural societies, followed by progression in over-the-counter drug sales, have provided new growth prospects for the pain management drugs market in Japan. Likewise, various key market players, namely Shionogi Inc. and Daiichi Sankyo, have well-established customer bases in Japan, and the companies are forming strategic collaborations with global firms such as Pfizer Inc. to improve their product offering, which is estimated to stimulate the market growth.
Japan Pain Management Drugs Market Scope:
| Report Metric | Details |
|---|---|
| Forecast Unit | Billion |
| Growth Rate | 2.98% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Segmentation | Drug Type, Distribution Channel, Indication, City |
| Geographical Segmentation | Tokyo, Yokohama, Osaka, Nagoya, Others |
| Companies |
|
| Customization Scope | 15% Free Customization included with purchase — Request Custom Breakdown → |
| Sample & Data Access | PDF Sample, Excel Databook & Analyst Briefing — Download Free Sample → |
Market Segmentation
By Drug Type
By Distribution Channel
By Indication
By City
Table of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. JAPAN PAIN MANAGEMENT DRUGS MARKET BY DRUG TYPE
5.1. Introduction
5.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
5.3. Corticosteroids
5.4. Acetaminophen
5.5. Opioid
5.5.1. Strong Opioid
5.5.2. Weak Opioid
5.6. Antidepressants
5.7. Anticonvulsant Drugs
5.8. Others
6. JAPAN PAIN MANAGEMENT DRUGS MARKET BY DISTRIBUTION CHANNEL
6.1. Introduction
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Online Pharmacies
7. JAPAN PAIN MANAGEMENT DRUGS MARKET BY INDICATION
7.1. Introduction
7.2. Cancer
7.3. Rheumatoid Arthritis
7.4. Chronic Back Pain
7.5. Post-Operative Pain
7.6. Others
8. JAPAN PAIN MANAGEMENT DRUGS MARKET BY CITY
8.1. Introduction
8.2. Tokyo
8.2.1. By Drug Type
8.2.2. By Distribution Channel
8.2.3. By Indication
8.3. Yokohama
8.3.1. By Drug Type
8.3.2. By Distribution Channel
8.3.3. By Indication
8.4. Osaka
8.4.1. By Drug Type
8.4.2. By Distribution Channel
8.4.3. By Indication
8.5. Nagoya
8.5.1. By Drug Type
8.5.2. By Distribution Channel
8.5.3. By Indication
8.6. Others
8.6.1. By Drug Type
8.6.2. By Distribution Channel
8.6.3. By Indication
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Novartis Pharmaceuticals Corporation (Novartis AG)
10.2. Eli Lilly and Company
10.3. Pfizer Inc.
10.4. GlaxoSmithKline plc
10.5. Sanofi S.A
10.6. Johnson & Johnson
10.7. Viatris Inc.
10.8. DAIICHI SANKYO COMPANY, LIMITED
10.9. Shionogi Inc.
10.10. Asahi Kasei Pharma Corporation.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
Frequently asked questions
What is the projected compound annual growth rate (CAGR) for the Japan Pain Management Drugs Market from 2025 to 2030?
The Japan Pain Management Drugs Market is anticipated to grow at a CAGR of 2.98% from 2025 to 2030. This growth is primarily attributed to the rising geriatric population, increasing prevalence of chronic pain conditions, and expanding healthcare access across the nation.
Which demographic factors are most significantly influencing the Japan Pain Management Drugs Market's growth?
The Japan Pain Management Drugs Market's growth is largely driven by Japan's rapidly aging population and improving life expectancy. The report highlights that the population aged 65 years and above is projected to account for 38.7% of the total by 2050, with seniors experiencing more age-related chronic pain conditions daily, thereby increasing the demand for pain management drugs.
What key indications are driving the demand for pain management drugs in Japan?
Demand for pain management drugs in Japan is significantly driven by a rising prevalence of chronic diseases, particularly cancer and rheumatoid arthritis. In 2022, nearly 1,005,157 new cancer cases were reported in Japan, leading to an increased need for effective pain control. The market also addresses chronic back pain and post-operative pain.
Are there specific distribution channel trends or over-the-counter (OTC) market progressions impacting the Japan Pain Management Drugs Market?
Yes, the market is experiencing significant progression in over-the-counter (OTC) drug sales, with consumers increasingly purchasing analgesics for everyday pain management. Additionally, favorable government policies are expanding healthcare access to rural societies, improving the availability of pain relief drugs through various distribution channels, including hospital, retail, and online pharmacies.
Who are the prominent market players and what is their strategic approach in the Japan Pain Management Drugs Market?
Key market players mentioned include Shionogi Inc. and Daiichi Sankyo, which possess well-established customer bases in Japan. These companies are actively forming strategic collaborations with global firms such as Pfizer Inc. to improve their product offerings and stimulate overall market growth in the country.
Does the report provide insights into pain management drug market trends and opportunities at a city level within Japan?
Yes, the report's scope explicitly includes analysis and forecasts 'By City' from 2025 to 2030, indicating a detailed geographical breakdown. While specific city-level data is not detailed in the provided excerpt, the report highlights government initiatives aimed at improving healthcare access and drug availability in rural areas nationwide, suggesting a comprehensive regional outlook within the full analysis.
Cite this report
Knowledge Sourcing Intelligence. (Mar 2026). Japan Pain Management Drugs Market - Strategic Insights and Forecasts (2025-2030). https://www.knowledge-sourcing.com/report/japan-pain-management-drugs-market